Quantum Cyber N.V. (QUCY)
NASDAQ: QUCY · Real-Time Price · USD
3.600
+0.140 (4.05%)
May 18, 2026, 2:10 PM EDT - Market open
Company Description
Quantum Cyber N.V. engages in the marketing and sale of colorectal cancer screening product candidates. It also develops PancAlert, a stool-based screening test aimed at detecting pancreatic cancer. The company is headquartered in Mainz, Germany.
Quantum Cyber N.V.
| Country | Germany |
| Founded | 2008 |
| IPO Date | Nov 5, 2021 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 13 |
| CEO | David Lazar |
Contact Details
Address: Robert Koch Strasse 50 Mainz, 55129 Germany | |
| Phone | 49 6131 554 2860 |
| Website | quantum-cyber.ai |
Stock Details
| Ticker Symbol | QUCY |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1874252 |
| ISIN Number | NL0015000LC2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| David Elliot Lazar | Chief Executive Officer and Director |
| William J. Caragol CPA | Chief Financial Officer and Senior Vice President |
| Dr. Christopher Von Toerne P.M.P., Ph.D. | Chief Operating Officer |
| Stefan Erlach | Head of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 15, 2026 | 10-Q | Quarterly Report |
| May 8, 2026 | 8-K | Current Report |
| Apr 28, 2026 | SCHEDULE 13D | Filing |
| Apr 28, 2026 | 8-K | Current Report |
| Apr 15, 2026 | 8-K | Current Report |
| Mar 31, 2026 | 10-K | Annual Report |
| Mar 25, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 25, 2026 | 8-K | Current Report |
| Mar 17, 2026 | 8-K | Current Report |
| Mar 12, 2026 | PRE 14A | Other preliminary proxy statements |